Related to this topic: Leaflets | Support | Equipment | Books | Your Experience | Other resources | Glossaries
Print options:
Other options:
(what's this?)
PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.
Detrusor Instability and Irritable Bladder
Synonym: overactive bladder syndrome
Is characterised by uncontrolled contraction of the bladder wall (detrusor muscle) producing urgency and sometimes leakage (urge incontinence). Involuntary detrusor contractions cause urgency and urge incontinence, often with frequency and nocturia. Detrusor instability can have a significant impact on quality of life.1
- Detrusor overactivity is the second commonest cause of female urinary incontinence behind stress incontinence
- 6.6% of European adults report these symptoms on questioning.
- Risk factors include multiple sclerosis and stroke but most cases have no specific cause
In men, urge incontinence may be due to neurological disease or an enlarged prostate (benign prostatic hypertrophy or prostate cancer).
Sudden urge to urinate that is very difficult to delay and may be associated with leakage. Also:
- Frequency of micturition
- Nocturia
- Abdominal discomfort
- Urge incontinence
There are no specific physical signs and the diagnosis is usually made from the symptoms and confirmed with urodynamic studies.
- Stress incontinence
- Functional incontinence
- Overflow incontinence
- Urinary fistula
- Enuresis
- Urinary tract infection
- Diabetes
- Bladder cancer
- Bladder stones
- Mid-stream urine M,C and S: to rule out urinary tract infection
- Investigations to consider differential diagnosis, e.g. renal function, electrolytes, fasting glucose
- Urodynamic studies show involuntary contraction of bladder during filling.
- Depending on the presentation, ultrasound of the renal tract and cystoscopy may be required.
Incontinence in adults which arises from detrusor instability is managed by combining drug therapy with conservative methods for managing urge incontinence such as pelvic floor exercises and bladder training.2 Sacral nerve stimulation is used in patients who do not respond to other treatments.3
Drugs
Anticholinergics4,5, e.g. oxybutynin, propiverine, tolterodine6, trospium chloride. Antimuscarinic drugs reduce involuntary detrusor contractions and increase bladder capacity.
- Oxybutynin also has a direct relaxant effect on urinary smooth muscle
- The efficacy and side-effects of tolterodine are comparable to those of modified-release oxybutynin. Flavoxate has less marked side-effects but it is also less effective.
- Propiverine, solifenacin and trospium are newer antimuscarinic drugs licensed for urinary frequency, urgency, and incontinence.
- The need for continuing antimuscarinic drug therapy should be reviewed after 3-6 months7
- Topical and systemic oestrogen can reduce urinary tract symptoms in post-menopausal women, especially urgency, frequency and dysuria, but is not effective in proven detrusor overactivity.
Surgery
- Surgery is only indicated for intractable and severe detrusor overactivity
- The most common procedure is an ileocystoplasty, in which the bladder is opened and a patch of ileum sutured into the bladder like a patch.
May cause severe social difficulties, including shopping, attending meetings, and therefore also psychological difficulties.
Document References
- Coyne KS, Zhou Z, Thompson C, et al; The impact on health-related quality of life of stress, urge and mixed urinary incontinence.; BJU Int. 2003 Nov;92(7):731-5. [abstract]
- Burgio KL, Goode PS, Locher JL, et al; Behavioral training with and without biofeedback in the treatment of urge incontinence in older women: a randomized controlled trial.; JAMA. 2002 Nov 13;288(18):2293-9. [abstract]
- NICE Technology Appraisals; Sacral nerve stimulation for urge incontinence and urgency-frequency. June 2004.
- Hay-Smith J, Herbison P, Ellis G, et al; Anticholinergic drugs versus placebo for overactive bladder syndrome in adults.; Cochrane Database Syst Rev. 2002;(3):CD003781. [abstract]
- Hay-Smith J, Herbison P, Ellis G, et al; Which anticholinergic drug for overactive bladder symptoms in adults.; Cochrane Database Syst Rev. 2005 Jul 20;(3):CD005429. [abstract]
- Kreder KJ Jr, Brubaker L, Mainprize T; Tolterodine is equally effective in patients with mixed incontinence and those with urge incontinence alone.; BJU Int. 2003 Sep;92(4):418-21. [abstract]
- BNF; Section 7.4.2 Urinary incontinence
DocID: 1684
Document Version: 20
DocRef: bgp2070
Last Updated: 10 Oct 2006
Review Date: 9 Oct 2008
Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.
Related pages in Patient UK
Your Experience (^ top of page)
Please add your experience about this condition / medicine
View patient experiences and discussions about this condition / medicine (6 there)Information leaflets related to this topic (^ top of page)
Overactive Bladder SyndromePatient Support related to this topic (^ top of page)
Cystitis and Overactive Bladder FoundationOther - Useful resources (^ top of page)
Pictures, diagrams, photos, images, etc.Evidence based medicine
Online textbooks and journals
A-Z of UK Guidelines
A-Z of Online Videos
Medline
Other good health sites
Medical equipment products related to this topic (^ top of page)

Books related to this topic (^ top of page)
Coping Successfully with Your Irritable Bladder
Irritable Bladder (Coping Successfully With Your)
Want to search some more? Use the Google Search box below to search our site.

Would you like to try our advanced on-line knowledge support system designed to provide professionals with relevant up to date information about recognition and management of disease or take the Mentor Challenge?
Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.
